Literature DB >> 31313718

Local Health Department Interest in Implementation of a Jail-Based Human Papillomavirus Vaccination Program in Kansas, Iowa, Missouri, and Nebraska.

Megha Ramaswamy1, Molly Allison, Brynne Musser, Catherine Satterwhite, Robert Armstrong, Patricia J Kelly.   

Abstract

CONTEXT: Local health departments (LHDs) play a vital role in community vaccination programs for human papillomavirus (HPV) infection, but little research has been done to assess LHD interest in cross-sectoral partnerships to vaccinate high-risk groups, specifically incarcerated persons.
OBJECTIVE: To describe factors associated with interest in a novel implementation strategy linking LHDs with jails in 4 Midwestern states to deliver HPV vaccine.
DESIGN: Survey based on the Consolidated Framework for Implementation Research (CFIR) model given to LHD administrators. A modified Poisson relative risk regression was used to assess the relationship between independent variables and LHD interest in implementation of a jail-based HPV vaccination program.
SETTING: LHDs in Kansas, Missouri, Iowa, and Nebraska. PARTICIPANTS: From September 2017 to April 2018, two-thirds (237/344) of invited LHD administrators from the 4 states responded to the survey. MAIN OUTCOME MEASURE: LHD interest in implementation of a jail-based HPV vaccination program.
RESULTS: Forty-five percent of LHDs were interested in learning more about implementing a jail-based HPV vaccination program, and 2% already offered or had plans to offer HPV vaccine in their jails. Barriers to implementation were cost (66%), inmates' short incarcerations (47%), and availability of medical staffing (43%). LHD characteristics associated with interest in implementation of a jail-based HPV vaccination program included "inner setting" CFIR variables, which capture the structural and cultural context for program implementation: 7 or more employees (odds ratio [OR] = 2.22; 95% confidence interval [CI], 1.24-3.95), perception of importance to provide HPV vaccine in jails (OR = 3.70; 95% CI, 2.00-6.84), and already providing any vaccines in jails (OR = 2.62; 95% CI, 1.18-5.80).
CONCLUSIONS: Nearly half of LHDs in the region expressed interest in partnering with local entities to meet HPV vaccination needs of high-risk groups. Research on cross-sectoral partnerships and what these collaborations look like in practice is needed for public health impact.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31313718      PMCID: PMC6954986          DOI: 10.1097/PHH.0000000000001021

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  24 in total

1.  Shifting Resources and Focus to Meet the Goals of the National HIV/AIDS Strategy: The Enhanced Comprehensive HIV Prevention Planning Project, 2010-2013.

Authors:  Stephen A Flores; David W Purcell; Holly H Fisher; Lisa Belcher; James W Carey; Cari Courtenay-Quirk; Erica Dunbar; Agatha N Eke; Carla A Galindo; Marlene Glassman; Andrew D Margolis; Mary Spink Neumann; Cynthia Prather; Dale Stratford; Raekiela D Taylor; Jonathan Mermin
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

2.  A Renewed Framework for Local Health Departments.

Authors:  Li-Wu Chen; Bruce Dart
Journal:  J Public Health Manag Pract       Date:  2019 Jan/Feb

3.  Epidemiology of cervical cancer: study of a prison population.

Authors:  K S Moghissi; H C Mack
Journal:  Am J Obstet Gynecol       Date:  1968-03-01       Impact factor: 8.661

4.  The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.

Authors:  Cosette M Wheeler; Susanne K Kjaer; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Gonzalo Perez; Darron R Brown; Laura A Koutsky; Eng Hseon Tay; Patricia García; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Sven-Eric Olsson; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Marc Steben; F Xavier Bosch; Joakim Dillner; Elmar A Joura; Robert J Kurman; Slawomir Majewski; Nubia Muñoz; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine Bryan; Lisa C Lupinacci; Katherine E D Giacoletti; Margaret James; Scott Vuocolo; Teresa M Hesley; Eliav Barr
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

5.  Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study.

Authors:  Rengaswamy Sankaranarayanan; Smita Joshi; Richard Muwonge; Pulikottil Okkuru Esmy; Partha Basu; Priya Prabhu; Neerja Bhatla; Bhagwan M Nene; Janmesh Shaw; Usha Rani Reddy Poli; Yogesh Verma; Eric Zomawia; Sharmila Pimple; Massimo Tommasino; Michael Pawlita; Tarik Gheit; Tim Waterboer; Peter Sehr; Madhavan Radhakrishna Pillai
Journal:  Vaccine       Date:  2018-03-15       Impact factor: 3.641

6.  Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science.

Authors:  Laura J Damschroder; David C Aron; Rosalind E Keith; Susan R Kirsh; Jeffery A Alexander; Julie C Lowery
Journal:  Implement Sci       Date:  2009-08-07       Impact factor: 7.327

7.  Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.

Authors:  Nubia Muñoz; Ricardo Manalastas; Punee Pitisuttithum; Damrong Tresukosol; Joseph Monsonego; Kevin Ault; Christine Clavel; Joaquin Luna; Evan Myers; Sara Hood; Oliver Bautista; Janine Bryan; Frank J Taddeo; Mark T Esser; Scott Vuocolo; Richard M Haupt; Eliav Barr; Alfred Saah
Journal:  Lancet       Date:  2009-06-01       Impact factor: 79.321

8.  Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Harrell W Chesson; C Robinette Curtis; Julianne Gee; Joseph A Bocchini; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2014-08-29

9.  Factors associated with smoking among adolescent males prior to incarceration and after release from jail: a longitudinal study.

Authors:  Megha Ramaswamy; Babalola Faseru; Karen L Cropsey; Marvia Jones; Karisa Deculus; Nicholas Freudenberg
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-10-31

10.  Developing measures to assess constructs from the Inner Setting domain of the Consolidated Framework for Implementation Research.

Authors:  Maria E Fernandez; Timothy J Walker; Bryan J Weiner; William A Calo; Shuting Liang; Betsy Risendal; Daniela B Friedman; Shin Ping Tu; Rebecca S Williams; Sara Jacobs; Alison K Herrmann; Michelle C Kegler
Journal:  Implement Sci       Date:  2018-03-27       Impact factor: 7.327

View more
  3 in total

1.  Barriers and facilitators of implementing a collaborative HPV vaccine program in an incarcerated population: A case study.

Authors:  Amanda Emerson; Molly Allison; Patricia J Kelly; Megha Ramaswamy
Journal:  Vaccine       Date:  2020-02-08       Impact factor: 3.641

2.  Recommendations for Delivering COVID-19 Vaccine in Jails: Evidence from Kansas, Iowa, Nebraska, and Missouri.

Authors:  Megha Ramaswamy; Catherine L Satterwhite; Ashlyn Lipnicky; Amanda Emerson; Phil Griffin; Donald Ash; Kevin Ault
Journal:  Am J Public Health       Date:  2021-06       Impact factor: 11.561

3.  Collaborating to offer HPV vaccinations in jails: results from a pre-implementation study in four states.

Authors:  Amanda Emerson; Molly Allison; Lisa Saldana; Patricia J Kelly; Megha Ramaswamy
Journal:  BMC Health Serv Res       Date:  2021-04-07       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.